Clin2
NCT06584552Likely a fitRecruiting

Testing a probiotic for early childhood eczema

EczemaAllergy

Part of Immune system & allergy, Skin clinical trials.

This study tests if a friendly bacteria called Lactobacillus paracasei, given as a powder, can help control eczema in young children. It's for kids 3 months to 3 years old with mild to moderate eczema who are not taking strong medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
3 months to 3 years
Study type
Interventional

Who can take part

  • Your child must be between 3 months and 3 years old.
  • A pediatric skin doctor or allergy doctor must have diagnosed your child with eczema.
  • Your child’s eczema must be mild to moderate — not severe or nearly gone.
  • Your child cannot be taking strong immune-suppressing medicines or biologics for eczema.
  • If your child takes probiotics, you must be willing to stop them for the study.
  • Your child cannot have a weak immune system, a serious active skin infection, or a chronic stomach/bowel condition.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06756438Recruiting
Cream for eczema in children – test of gentle skin care

This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.

Gdansk, Poméranie
NCT06807268Recruiting· Phase 3
A study of abrocitinib for children ages 6–11 with eczema

This trial tests a daily pill called Abrocitinib to see if it can help children ages 6 to 11 with moderate-to-severe eczema that hasn't gotten better with creams or ointments. Eczema (also called atopic dermatitis) causes itchy, red skin, and this medicine might calm the immune response to reduce itching and rashes.

Birmingham, Alabama
NCT07701447Not yet recruiting
Probiotic cream for children with eczema

This study tests a probiotic ointment for children aged 6 months to 15 years with mild-to-moderate eczema (measured by a skin score of 15–50). It aims to see if the cream is safe and helps improve their skin.

NCT07490587Recruiting· Phase 2
Probiotic study for healthy infant growth and allergy prevention

This trial tests a probiotic supplement (Bifidobacterium animalis subsp. lactis XLTG11) to see if it helps infants grow better and have fewer allergies. It is for healthy babies up to 3 years old who are at higher risk for allergies.

Pudong, Shanghai Municipality
NCT07713303Not yet recruiting
Probiotic cream study for children with dry skin

This study tests a cream containing probiotics (good bacteria) for children with dry skin. It aims to see if the cream is safe and helps improve dryness.

Lisbon
NCT07758933Not yet recruiting· Phase 1/Phase 2
Safety of a probiotic supplement for children with diarrhea and weakened immune systems

This trial tests whether a probiotic supplement called Lactéol® is safe for children with weakened immune systems who have diarrhea. The study aims to help manage diarrhea and improve outcomes for these children.

Cuahutemoc, Mexico City

Hear when a new Eczema trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.